From: An antibody microarray analysis of serum cytokines in neurodegenerative Parkinsonian syndromes
PDGF-BB (ng/ml) | Prolactin (ng/ml) | |
---|---|---|
Disease: | ||
PSP/CBS (n = 38) a | 8.7 (2.7-12.6) | 3.4 (0.3-41.2) |
MSA (n = 31) a | 8.4 (2.9-11.6) | 3.3 (0.1-74.1) |
PD (n = 117) a | 6.9 (3.0-12.7) | 2.3 (0.0-35.1) |
Controls (n = 99) a | 5.9 (2.0-10.8) | 3.7 (0.5-37.5) |
p = 4x10-7 b | p = 3x10-7 b | |
Females (n = 132) a | 6.7 (2.4-12.7) | 3.1 (0.0-74.1) |
Males (n = 153) a | 6.8 (2.0-12.0) | 3.3 (0.0-37.4) |
p = ns c | p = ns c | |
Age, y | R = 0.006 | R = −0.040 |
p = ns d | p = ns d | |
Duration, y | R = −0.183 | R = −0.226 |
p = ns d | p = ns d | |
Hoehn&Yahr | R = 0.105 | R = 0.217 |
p = ns e | p = 0.02 e | |
Dementia (n = 31) a | 8.3 (4.2-12.6) | 3.1 (0.0-35.1) |
No Dementia (n = 148) a | 7.1 (2.6-12.7) | 2.7 (0.0-74.1) |
p = 0.038 c | p = ns c | |
Parkinson treatment: | ||
None (n = 48) a | 6.5 (2.0-12.7) | 3.6 (0.2-37.5) |
LD (n = 48) a | 7.4 (2.7-12.6) | 4.0 (0.0-74.1) |
DA (n = 8) a | 6.6 (3.7-8.6) | 0.0 (0.0-3.1) |
MAO-B Inh. (n = 8) a | 8.1 (5.5-11.4) | 2.8 (1.7-4.7) |
LD + DA (n = 48) a | 6.1 (2.9-11.4) | 0.2 (0.0-33.2) |
LD + MAO-B Inh. (n = 12) a | 10.3 (5.0-11.7) | 9.4 (0.3-41.2) |
LD + DA + MAO-B Inh. (n = 7) a | 6.9 (5.6-10.4) | 0.3 (0.0-19.9) |
p = 0.002 b | p = 7x10-13 b |